Presentations: Leipzig Interventional Course – interdisciplinary global platform for endovascular interventions

Room 1 - Main Arena 1

22 events

Tuesday, January 30th: 8:00 - 9:30, Room 1 - Main Arena 1

SYMPOSIUM: Present and future clinical use for vascular mimetic stents

supported with an educational grant from Abbott Vascular

Moderator:

Dierk Scheinert

Panel:

Enrique San Norberto-García, Jörg Teßarek, Peter Goverde
1. 08:00 - 08:07
  
  2-year data Supera popliteal real world
2. 08:07 - 08:14
  
  Supera in popliteal aneursym
3. 08:14 - 08:45
  
  Live case transmission from Leipzig
4. 08:45 - 08:52
  
  Preliminary 6-month results of VMI CFA trial
5. 08:52 - 08:59
  
  NEW DAWN: 1-year results of the combination DCBs and Supera stent for the treatment of long femoropoliteal lesions
6. 08:59 - 09:30
  
  Live case transmission from Leipzig
Tuesday, January 30th: 9:30 - 11:00, Room 1 - Main Arena 1

Latest results with new technologies for femoropopliteal obstructions: drug-eluting devices, atherectomy and new implants

Moderator:

Dierk Scheinert

Panel:

Marianne Brodmann, Thomas Zeller, Steven Kum, Wei Guo
1. 09:30 - 09:35
  
  EFFPAC–RCT: Final 6-months results with the Luminor DCB in femoropopliteal lesions
2. 09:35 - 09:40
  
  ILLUMENATE EU RCT: 2-year results with the Stellarex DCB in femoropopliteal lesions
3. 09:40 - 09:45
  
  FIRST TIME DATA RELEASE: CONSEQUENT RCT: 2-year results with the SeQuent Please OTW DCB
4. 09:45 - 09:50
  
  FIRST TIME DATA RELEASE: IN.PACT Japan RCT of DCB vs. PTA: 2-year results
5. 09:50 - 09:55
  
  FIRST TIME DATA RELEASE: ILLUMENATE GLOBAL: 2-year results of the Stellarex DCB in femoropoliteal lesions
6. 09:55 - 10:00
  
  DANCE trial (ATX and PTA groups) – 2-year results
7. 10:00 - 10:05
  
  Long term durability of DCB treatment in the SFA: 4-year results of the IN.PACT SFA study
8. 10:05 - 10:10
  
  Outcomes of DCB use in real-world patients: 2-year results from the IN.PACT global registry
9. 10:10 - 10:15
  
  FIRST TIME DATA RELEASE: LUTONIX long lesion study: 2-year outcomes
10. 10:15 - 10:20
  
  FIRST TIME DATA RELEASE: COMPARE-Pilot RCT: 1-year results of a randomised comparison of RANGER DCB vs. IN.PACT DCB in complex SFA lesions
11. 10:20 - 10:25
  
  FIRST TIME DATA RELEASE: Outcomes of DCB use in femoropopliteal lesions of patients with CLI (RCC4/5): Subgroup analysis of IN.PACT global study
12. PROMISE AND LIMITATIONS OF DCB – WHAT HAVE WE LEARNED?
13. 10:25 - 10:30
  
  DCB from a preclinical perspective: The relevance of paclitaxel dose and coating integrity
14. 10:30 - 10:35
  
  DCB from a clinical perspective: What is proven and where are the open questions and limitations?
15. 10:35 - 10:40
  
  Panel discussion
16. 10:40 - 10:45
  
  Update on the TOBA studies in the femoropopliteal arteries
17. 10:45 - 10:50
  
  FIRST TIME DATA RELEASE: LOCOMOTIVE All Comers Study with the VascuFlex Multi-LOC spot stenting device: 12-month results
18. 10:50 - 10:55
  
  FIRST TIME DATA RELEASE: 1-year results from the MIMICS-2 Study; US, German, and Japanese experience with the BioMimics 3D stent
19. 10:55 - 11:00
  
  Discussion and conclusion
Tuesday, January 30th: 11:00 - 12:30, Room 1 - Main Arena 1

SYMPOSIUM: Patient first: “Leave the right thing behind”. Debating evidence to provide the answers

supported with an educational grant from COOK Medical

Moderator:

Iris Baumgartner-Peuker

Panel:

Thomas Zeller, Fabrizio Fanelli, Aloke Finn, Marc Bosiers
1. 11:00 - 11:05
  
  Introduction
2. 11:05 - 11:13
  
  XPEDITE study
3. 11:13 - 11:21
  
  DCB + BMS is not a DES
4. 11:21 - 11:41
  
  Live case transmission from Leipzig
5. 11:41 - 11:49
  
  Understanding restenosis in the SFA
6. 11:49 - 11:57
  
  First results of the ZILVERPASS study
7. 11:57 - 12:17
  
  Live case transmission from Jena
8. 12:17 - 12:25
  
  The importance of scientific evidence
9. 12:25 - 12:30
  
  Summing up on symposium discussion and debate
Tuesday, January 30th: 12:30 - 13:30, Room 1 - Main Arena 1

Lunch
Tuesday, January 30th: 13:30 - 15:00, Room 1 - Main Arena 1

Leave nothing behind 2.0: Combination therapy to advance SFA treatment strategy

supported with an educational grant from Medtronic

Moderator:

Dierk Scheinert

Panel:

Krishna Rocha-Singh, Wei Guo
1. 13:30 - 13:35
  
  Introduction
2. 13:35 - 13:45
  
  SFA disease management: Are the longterm outcomes with IN.PACT DCB changing the peripheral landscape?
3. 13:45 - 14:05
  
  Live case transmission from New York
4. 14:05 - 14:15
  
  Dose matters: Understanding the science behind DCB outcomes
5. 14:15 - 14:25
  
  From Chocolate to Hawk: Vessel preparation for improved outcomes
6. 14:25 - 14:45
  
  Live case transmission from Cotignola
7. 14:45 - 15:00
  
  Discussion and conclusion
Tuesday, January 30th: 15:00 - 16:30, Room 1 - Main Arena 1

SYMPOSIUM: Going further with drug eluting technology in peripheral arterial disease: From SFA to below the knee challenges.

supported with an educational grant from Boston Scientific

Moderator:

Dierk Scheinert

Panel:

Marc Sapoval, Hans van Overhagen, Jihad Mustapha
1. 15:00 - 15:03
  
  Opening and learning objectives
2. 15:03 - 15:10
  
  Current data and performance of drug eluting technology in SFA
3. 15:10 - 15:17
  
  BTK intervention with drug coated balloons. Past lessons and future exploration
4. 15:17 - 15:47
  
  Live case transmission from Leipzig
5. 15:47 - 15:54
  
  Drug eluting stents in BTK intervention – a review
6. 15:54 - 16:01
  
  Next steps in drug eluting stent for BTK intervention
7. 16:01 - 16:08
  
  Clinical targets and patient outcome goals in BTK intervention
8. 16:08 - 16:25
  
  Panel discussion
9. 16:25 - 16:30
  
  Closing remarks
Tuesday, January 30th: 16:30 - 18:00, Room 1 - Main Arena 1

Advanced solutions for calcified lesions and CTOs

Moderator:

Ramon Varcoe, Thomas Zeller

Panel:

Richard Heuser, Gunnar Tepe, Andrew Holden, Krishna Rocha-Singh, Darren Schneider, Arne Schwindt
1. 16:30 - 16:36
  
  Vessel preparation: What does it mean and what are the current tools (PTA, DA and scoring balloons)?
2. 16:36 - 16:41
  
  Impact of chronic total occlusion on outcomes: IN.PACT global CTO imaging cohort
3. 16:41 - 17:02
  
  Live case transmission from New York
4. 17:02 - 17:08
  
  Understanding the challenges with measuring calcium in DCB clinical trials
5. 17:08 - 17:14
  
  Vascular calcium: new pre-clinical models and new treatment solutions
6. 17:14 - 17:19
  
  Clinical experience with the Phoenix atherectomy system for complex calcified lesions
7. 17:19 - 17:25
  
  Applications of Lithoplasty for the treatment of calcified lesions
8. 17:25 - 17:30
  
  Shockwave Lithoplasty System treatment of calcified lesions: Intravascular OCT analysis
9. 17:30 - 17:50
  
  Live case transmission from Leipzig
10. 17:50 - 17:55
  
  The “Crack and Pave” technique for highly resistant calcified lesions: Initial results
11. 17:55 - 18:00
  
  Discussion and conclusion
Wednesday, January 31st: 8:00 - 9:30, Room 1 - Main Arena 1

Below-the-knee revascularisation: Current status, challenges, and future outlook

Moderator:

Dierk Scheinert, Peter Schneider

Panel:

Jihad Mustapha, Steven Kum, Kazushi Urasawa, Osamu Iida
1. 08:00 - 08:05
  
  Comprehensive meta-analysis of endovascular versus bypass for critical limb ischemia – is bypass obsolete?
2. 08:05 - 08:10
  
  Three-year outcomes of surgical vs. endovascular revascularisation for critical limb ischemia: The Surgical reconstruction vs. Peripheral INtervention in pAtients with critical limb isCHemia (SPINACH) study
3. 08:10 - 08:17
  
  Retrograde tibial puncture has changed our algorithm for crossing tibial lesions in CLI: How and when to do it?
4. 08:17 - 08:24
  
  Advanced crossing and wiring techniques in BTK vessels
5. 08:24 - 08:51
  
  Live case transmission from Leipzig
6. 08:51 - 08:58
  
  Technical considerations for successful use of DCBs in BTK arteries: Lessons learned from preclinical studies
7. 08:58 - 09:03
  
  Update on the LUTONIX BTK Global Registry: First look at 300 patient interim follow up data
8. 09:03 - 09:10
  
  Patterns of vessel calcification in BTK arteries and implications for vessel preparation and atherectomy
9. 09:10 - 09:15
  
  Update on the Optimize BTK trial (Atherectomy with the CSI atherectomy catheter in combination with DCB in calcified BTK lesions)
10. 09:15 - 09:20
  
  Lithoplasty – also an option for calcified BTK vessels? Update on the Shockwave BTK study
11. 09:20 - 09:25
  
  Update on TOBA below-the-knee
12. 09:25 - 09:30
  
  Adventitial drug therapy below-the-knee: Update on LIMBO and TANGO
Wednesday, January 31st: 9:30 - 11:00, Room 1 - Main Arena 1

Symposium: DCB progress update: science, evidence, and vessel prep algorithms

supported with an educational grant from Spectranetics, a Philips Company

Moderator:

Gunnar Tepe, Sean Lyden

Panel:

Ehrin Armstrong, Simon Bays
1. 09:30 - 09:33
  
  Introduction
2. 09:33 - 09:40
  
  Requirements and specificities of a low-dose DCB: the Stellarex case example
3. 09:40 - 09:47
  
  Stellarex level 1 evidence in common to complex patients
4. 09:47 - 10:07
  
  Live case transmission from Leipzig
5. 10:07 - 10:14
  
  As simple as scoring: Angiosculpt vessel prep and case review
6. 10:14 - 10:21
  
  In-stent-restenosis: new evidence from laser + DCB
7. 10:21 - 10:41
  
  Live case transmission from Leipzig
8. 10:41 - 11:00
  
  Discussion and conclusion
Wednesday, January 31st: 11:00 - 12:30, Room 1 - Main Arena 1

Symposium: Extended indication for the new GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis

supported with an educational grant from Gore & Associates

Moderator:

Mauro Gargiulo

Panel:

Giovanni Torsello, Michele Antonello, Chris Metzger, Michel Reijnen
1. 11:00 - 11:05
  
  Introduction by chairman
2. 11:05 - 11:15
  
  Complexity of iliac occlusive disease, current treatment algorithm, and treatment gaps
3. 11:15 - 11:25
  
  2-year outcomes from the GORE. VIABAHN. VBX Balloon Expandable IDE study
4. 11:25 - 11:40
  
  Recorded case presentation from Arnhem (NL)
5. 11:40 - 11:50
  
  Aortic challenges, quantitative analysis in fenestrated procedures
6. 11:50 - 12:05
  
  Recorded case presentation from Münster
7. 12:05 - 12:30
  
  Discussion and conclusion by chairman
Wednesday, January 31st: 12:30 - 13:30, Room 1 - Main Arena 1

Lunch
Wednesday, January 31st: 13:30 - 15:00, Room 1 - Main Arena 1

Symposium: Lutonix® Drug Coated Balloon – Evidence in SFA, BTK, and AV

supported with an educational grant from C. R. BARD

Moderator:

Dierk Scheinert

Panel:

Aloke Finn, Scott Trerotola, Luis Mariano Palena, Kate Steiner, Martin Banyai
1. 13:30 - 13:35
  
  Introduction
2. 13:35 - 13:45
  
  Are all DCBs the same?
3. 13:45 - 13:55
  
  Treatment of TASC C & D lesions with DCB
4. 13:55 - 14:05
  
  Is DCB treatment right for below-the-knee patients?
5. 14:05 - 14:15
  
  Management of recurring infrapopliteal disease in diabetic patients with critical limb ischemia – a single center experience
6. 14:15 - 14:25
  
  Long term benefit effects of Lutonix 035 DCB
7. 14:25 - 14:35
  
  The role of Lutonix DCB in AV fistula dysfunction management in our practice
8. 14:35 - 14:45
  
  DCB outcomes in real world patients with restenotic AV fistula
9. 14:45 - 15:00
  
  Live case transmission from Leipzig
Wednesday, January 31st: 15:00 - 16:30, Room 1 - Main Arena 1

VIVA@LINC: Facing the future with a look 10 years forward

Moderator:

John Laird, Peter Schneider

Panel:

Dierk Scheinert, Krishna Rocha-Singh, Chris Metzger
1. 15:00 - 15:05
  
  Announcement of the winners of the Vascular Career Award 2017
2. 15:05 - 15:13
  
  Type B aortic dissection: Endovascular grafting will be required in most patients
3. 15:13 - 15:39
  
  Live case transmission from Teaneck
4. 15:39 - 15:47
  
  Drug-coated balloons: Will be used in every vascular bed, yes or no?
5. 15:47 - 15:55
  
  The breakthrough in complex tibial and pedal revascularisation will be….
6. 15:55 - 16:22
  
  Live case transmission from Teaneck
7. 16:22 - 16:30
  
  We will have agreed upon indications for repair of asymptomatic carotid atenosis, yes or no?
Wednesday, January 31st: 16:30 - 18:00, Room 1 - Main Arena 1

The last frontiers: Endovascular therapy of the common femoral artery and the popliteal segment

Moderator:

Marc Bosiers, Lawrence Garcia

Panel:

Chris Metzger, Ulrich Beschorner, Ralph-Ingo Rückert, Martin Malina, Darren Schneider
1. 16:30 - 16:37
  
  Is it now time for endovascular techniques to conquer the CFA?
2. 16:37 - 16:42
  
  Complex stenting of the common femoral artery
3. 16:42 - 16:47
  
  Recanalisation of femoral bifurcations using the Culotte stent technique
4. 16:47 - 16:52
  
  The VMI-CFA study: A physician-initiated study investigating the Supera stent in the common femoral artery (preliminary 6-month results)
5. 16:52 - 17:15
  
  Live case transmission from Bad Krozingen
6. 17:15 - 17:20
  
  Drug-eluting treatments of the common femoral artery – the last frontier
7. 17:20 - 17:25
  
  Combined use of directional atherectomy and DCB for the treatment of the CFA: immediate and one-year outcomes
8. 17:25 - 17:50
  
  Live case transmission from Leipzig
9. 17:50 - 17:55
  
  DCB for popliteal artery stenosis: Update from the IN.PACT Flexion trial
10. 17:55 - 18:00
  
  Results from the 100 patients of the prospective TIGRIS Vienna study
Thursday, February 1st: 8:00 - 9:30, Room 1 - Main Arena 1

The last frontiers: Extreme BTK interventions

Moderator:

Peter Schneider, Roberto Ferraresi

Panel:

Hiroyoshi Yokoi, Olaf Bakker, Miguel Montero-Baker, Steven Kum, Antonio Micari
1. 08:00 - 08:20
  
  Live case transmission from Leipzig
2. 08:20 - 08:27
  
  Micro knuckle technique: Quick and easy recanalisation of re-occluded BTK arteries
3. 08:27 - 08:34
  
  DCB for BTK arteries: New technologies and latest data
4. 08:34 - 08:41
  
  Adventitial drug delivery for treatment of infrapopliteal critical limb ischemia
5. 08:41 - 08:48
  
  When is below-the-ankle angioplasty indicated and how to introduce it into your practice?
6. 08:48 - 09:09
  
  Live case transmission from Abano Terme
7. 09:09 - 09:16
  
  Dorsalis pedis artery entrapment: curiosity or clinical issue in CLI patients?
8. 09:16 - 09:23
  
  How to assess procedural success in complex CLI-settings? Initial OMNIA results: unique tool in the assessment and clinical management of CLI
9. 09:23 - 09:30
  
  Angio-perfusion imaging in CLI-patients with pharmacological and catheter-based interventions? Can we predict outcome?
Thursday, February 1st: 9:30 - 11:00, Room 1 - Main Arena 1

Symposium: The role of purely mechanical debulking in thrombus containing lesions in arteries and veins

supported with an educational grant from Straub Medical

Moderator:

Gerard O'Sullivan

Panel:

Bruno Migliara, Miroslav Bulvas, Romaric Loffroy, Steven Kum
1. 09:30 - 09:33
  
  Introduction
2. 09:33 - 09:40
  
  ISR-treatment – The Leipzig experience with purely mechanical debulking
3. 09:40 - 10:00
  
  Live case transmission from Leipzig
4. 10:00 - 10:07
  
  Mechanical debulking in bypass occlusions – very fast and highly effective
5. 10:07 - 10:27
  
  Live case transmission from Leipzig
6. 10:27 - 10:34
  
  Setting up a deep venous service in your hospital
7. 10:34 - 10:41
  
  Our patients with acute proximal DVT – Effective thrombus removal with purely mechanical thrombectomy can lead to better outcomes
8. 10:41 - 11:00
  
  Discussion and conclusion
Thursday, February 1st: 11:00 - 12:30, Room 1 - Main Arena 1

The remaining challenges: Long lesions and in-stent-restenosis (ISR)

Moderator:

George Adams, Dai-Do Do

Panel:

Torsten Fuß, Jos van den Berg, Hans Krankenberg, Sabine Steiner, Chris Metzger
1. 11:00 - 11:06
  
  Endovascular treatment of severe TASC C & D lesion with Gore® Viabahn endoprosthesis
2. 11:06 - 11:11
  
  Comparing endoluminal to open fempop bypasses: Final 2-year results of the SUPER B trial
3. 11:11 - 11:17
  
  2-year results of a novel Bi-Directional SFA stent design: A comparative study of safety and efficacy
4. 11:17 - 11:42
  
  Live case transmission from Leipzig
5. 11:42 - 11:48
  
  The ZILVERPASS study: a randomised study comparing ZILVER PTX stenting with bypass in femoropopliteal lesions (preliminary 12-month results)
6. 11:48 - 11:53
  
  2-year results of the COPA CABANA RCT of DCB vs. PTA for femoropopliteal ISR
7. 11:53 - 11:59
  
  New evidence from Laser + DCB in ISR
8. 11:59 - 12:24
  
  Live case transmission from Bad Krozingen
9. 12:24 - 12:30
  
  “Crush stenting” – an alternative approach to manage occluded femoropopliteal stents
Thursday, February 1st: 12:30 - 13:25, Room 1 - Main Arena 1

Lunch symposium: Live case with Dr. Andrej Schmidt: Options for crossing

supported with a restricted educational grant from COOK Medical

Moderator:

Peter Schneider

Panel:

Roberto Ferraresi, William Loan

live with:

Andrej Schmidt
1. Welcome
2. What you need to know about crossing BTK lesions
3. Live case transmission from Leipzig and panel discussion
4. Panel discussion
Thursday, February 1st: 13:30 - 15:00, Room 1 - Main Arena 1

Glimpse into the future: Pioneering technique to master the remaining challenges in endovascular interventions

Moderator:

William Gray, Andrew Holden

Panel:

Richard Heuser, Aloke Finn, Krishna Rocha-Singh, Tony Das
1. 13:30 - 13:35
  
  Advances in atherectomy: Phoenix atherectomy – why, when, and how?
2. 13:35 - 13:40
  
  Phoenix registry interim data
3. 13:40 - 14:00
  
  Live case transmission from Leipzig
4. 14:00 - 14:06
  
  Polypharmacy and the future of PAD and CLI drug therapy
5. 14:06 - 14:12
  
  Fusion techniques for treatment of peripheral artery interventions
6. 14:12 - 14:18
  
  Percutaneous transvenous prosthetic arterial bypass for long complicated fem-pop occlusions: The PQ Bypass procedure
7. 14:18 - 14:40
  
  Live case transmission from Münster
8. 14:40 - 14:45
  
  Update on the DETOUR I study: 12-month data
9. 14:45 - 14:50
  
  Clinical experience and latest clinical data with the EndoAVF technology
10. 14:50 - 15:00
  
  Recorded case presentation
Thursday, February 1st: 15:00 - 16:30, Room 1 - Main Arena 1

New concepts for AV-shunt revascularisation and central vein stenoses

Moderator:

Andrew Holden, Bart Dolmatch

Panel:

Scott Trerotola, Konstantinos Katsanos, Panagiotis Kitrou, Ayman Al-Sibaie
1. 15:00 - 15:07
  
  How the past leads to the future – A review of AV-shunt treatment options
2. 15:07 - 15:14
  
  Lysis-Assisted Balloon (LAB) thrombectomy. A declotting technique for the treatment of thrombosed arteriovenous dialysis grafts. 5-year experience of 241 procedures
3. 15:14 - 15:42
  
  Live case transmission from Teaneck
4. 15:42 - 15:49
  
  Technical aspects of treating AVF with IN.PACT DCB
5. 15:49 - 15:54
  
  Long term benefit from Lutonix 035 AV IDE trial
6. 15:54 - 15:59
  
  First interim look at the LUTONIX® DCB AV registry
7. 15:59 - 16:04
  
  Update on the IN.PACT AV access trial
8. 16:04 - 16:09
  
  Treatment options for critical hand ischemia: A single center experience
9. 16:09 - 16:19
  
  Live case transmission from Teaneck
10. 16:19 - 16:30
  
  Discussion and conclusion
Thursday, February 1st: 16:30 - 18:00, Room 1 - Main Arena 1

The last frontiers: Extreme Ilio-femoral interventions

Moderator:

Tony Das, Kazushi Urasawa

Panel:

Thomas Rand, Hans Krankenberg, Thomas Heller
1. 16:30 - 16:37
  
  Balloon expandable covered stents in aorta-iliac occlusive disease: Suddenly a crowded space
2. 16:37 - 16:44
  
  Hybrid revascularisation techniques for complex peripheral arterial occlusions
3. 16:44 - 17:12
  
  Live case transmission from Leipzig
4. 17:12 - 17:19
  
  Distal puncture and bidirectional wiring techniques: Key role in the treatment of long femoro-popliteal occlusive disease
5. 17:19 - 17:26
  
  Results of 300 consecutive retrograde recanalisations of complex femoropopliteal or below-the-knee occlusions
6. 17:26 - 17:55
  
  Live case transmission from Bad Krozingen
7. 17:55 - 18:00
  
  Discussion and conclusion
Friday, February 2nd: 9:00 - 13:00, Room 1 - Main Arena 1

Critical issues and pioneering solutions in aortic endografting

Moderator:

Martin Malina, Eric Ducasse

Panel:

Giovanni Torsello, Marc van Sambeek, Thomas Larzon, Piotr Kasprzak, Reza Ghotbi
1. 09:00 - 09:40
  
  Live case transmission from Münster
2. 09:40 - 09:47
  
  A new concept to evaluate decision making factors for the treatment of complex aortic aneurysms
3. 09:47 - 09:54
  
  Evolution of gender-related differences in outcome of EVAR
4. 09:54 - 10:01
  
  Workflow innovation for optimized hybrid OR performance
5. 10:01 - 10:08
  
  The role of 2D and 3D fusion imaging for reconstruction of complex aortic pathologies
6. 10:08 - 10:15
  
  Evolvement of interventional imaging and dose reduction techniques for image guided endovascular treatment of complex aortic pathologies
7. 10:15 - 10:55
  
  Live case transmission from Leipzig
8. 10:55 - 11:02
  
  Branch for IMA in branched EVAR – when and why?
9. 11:02 - 11:09
  
  Connection of a celiac artery to branched stent-graft by retrograde access through SMA
10. 11:09 - 11:16
  
  One case of dissection Type B treated by new technique FIL&FIS (Fusion Images, Laser & Fenestration In Situ)
11. 11:16 - 11:23
  
  All axillary artery approach for repair of complex thoracoabdominal aneurysms
12. 11:23 - 11:30
  
  Endovascular treatment of ruptured thoracoabdominal aneurysms
13. 11:30 - 11:37
  
  Infectious complications of the aorta – how to approach
14. 11:37 - 12:17
  
  Live case transmission from Münster
15. 12:17 - 12:24
  
  Total endovascular aortic arch replacement with chimney/ sandwich techniques
16. 12:24 - 12:31
  
  Staged repair of chronic Type A dissection
17. 12:31 - 12:38
  
  Sandwich-graft technique to preserve both internal iliac arteries in a patient with previous aorto-aortic bypass and external iliac artery occlusion
18. 12:38 - 13:00
  
  Discussion and conclusion

Notice

LINC 2018 presentations

Room 1 - Main Arena 1

SYMPOSIUM: Present and future clinical use for vascular mimetic stents

2-year data Supera popliteal real world

Supera in popliteal aneursym

Live case transmission from Leipzig

Preliminary 6-month results of VMI CFA trial

NEW DAWN: 1-year results of the combination DCBs and Supera stent for the treatment of long femoropoliteal lesions

Live case transmission from Leipzig

Latest results with new technologies for femoropopliteal obstructions: drug-eluting devices, atherectomy and new implants

EFFPAC–RCT: Final 6-months results with the Luminor DCB in femoropopliteal lesions

ILLUMENATE EU RCT: 2-year results with the Stellarex DCB in femoropopliteal lesions

FIRST TIME DATA RELEASE: CONSEQUENT RCT: 2-year results with the SeQuent Please OTW DCB

FIRST TIME DATA RELEASE: IN.PACT Japan RCT of DCB vs. PTA: 2-year results

FIRST TIME DATA RELEASE: ILLUMENATE GLOBAL: 2-year results of the Stellarex DCB in femoropoliteal lesions

DANCE trial (ATX and PTA groups) – 2-year results

Long term durability of DCB treatment in the SFA: 4-year results of the IN.PACT SFA study

Outcomes of DCB use in real-world patients: 2-year results from the IN.PACT global registry

FIRST TIME DATA RELEASE: LUTONIX long lesion study: 2-year outcomes

FIRST TIME DATA RELEASE: COMPARE-Pilot RCT: 1-year results of a randomised comparison of RANGER DCB vs. IN.PACT DCB in complex SFA lesions

FIRST TIME DATA RELEASE: Outcomes of DCB use in femoropopliteal lesions of patients with CLI (RCC4/5): Subgroup analysis of IN.PACT global study

PROMISE AND LIMITATIONS OF DCB – WHAT HAVE WE LEARNED?

DCB from a preclinical perspective: The relevance of paclitaxel dose and coating integrity

DCB from a clinical perspective: What is proven and where are the open questions and limitations?

Panel discussion

Update on the TOBA studies in the femoropopliteal arteries

FIRST TIME DATA RELEASE: LOCOMOTIVE All Comers Study with the VascuFlex Multi-LOC spot stenting device: 12-month results

FIRST TIME DATA RELEASE: 1-year results from the MIMICS-2 Study; US, German, and Japanese experience with the BioMimics 3D stent

Discussion and conclusion

SYMPOSIUM: Patient first: “Leave the right thing behind”. Debating evidence to provide the answers

Introduction

XPEDITE study

DCB + BMS is not a DES

Live case transmission from Leipzig

Understanding restenosis in the SFA

First results of the ZILVERPASS study

Live case transmission from Jena

The importance of scientific evidence

Summing up on symposium discussion and debate

Lunch

Leave nothing behind 2.0: Combination therapy to advance SFA treatment strategy

Introduction

SFA disease management: Are the longterm outcomes with IN.PACT DCB changing the peripheral landscape?

Live case transmission from New York

Dose matters: Understanding the science behind DCB outcomes

From Chocolate to Hawk: Vessel preparation for improved outcomes

Live case transmission from Cotignola

Discussion and conclusion

SYMPOSIUM: Going further with drug eluting technology in peripheral arterial disease: From SFA to below the knee challenges.

Opening and learning objectives

Current data and performance of drug eluting technology in SFA

BTK intervention with drug coated balloons. Past lessons and future exploration

Live case transmission from Leipzig

Drug eluting stents in BTK intervention – a review

Next steps in drug eluting stent for BTK intervention

Clinical targets and patient outcome goals in BTK intervention

Panel discussion

Closing remarks

Advanced solutions for calcified lesions and CTOs

Vessel preparation: What does it mean and what are the current tools (PTA, DA and scoring balloons)?

Impact of chronic total occlusion on outcomes: IN.PACT global CTO imaging cohort

Live case transmission from New York

Understanding the challenges with measuring calcium in DCB clinical trials

Vascular calcium: new pre-clinical models and new treatment solutions

Clinical experience with the Phoenix atherectomy system for complex calcified lesions

Applications of Lithoplasty for the treatment of calcified lesions

Shockwave Lithoplasty System treatment of calcified lesions: Intravascular OCT analysis

Live case transmission from Leipzig

The “Crack and Pave” technique for highly resistant calcified lesions: Initial results

Discussion and conclusion

Below-the-knee revascularisation: Current status, challenges, and future outlook

Comprehensive meta-analysis of endovascular versus bypass for critical limb ischemia – is bypass obsolete?

Three-year outcomes of surgical vs. endovascular revascularisation for critical limb ischemia: The Surgical reconstruction vs. Peripheral INtervention in pAtients with critical limb isCHemia (SPINACH) study

Retrograde tibial puncture has changed our algorithm for crossing tibial lesions in CLI: How and when to do it?

Advanced crossing and wiring techniques in BTK vessels

Live case transmission from Leipzig

Technical considerations for successful use of DCBs in BTK arteries: Lessons learned from preclinical studies

Update on the LUTONIX BTK Global Registry: First look at 300 patient interim follow up data

Patterns of vessel calcification in BTK arteries and implications for vessel preparation and atherectomy